Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» OncoSec inks deal with Merck to study drug-device therapy for metastatic melanoma
OncoSec inks deal with Merck to study drug-device therapy for metastatic melanoma
OncoSec inks deal with Merck to study drug-device therapy for metastatic melanoma
Submitted by
admin
on May 11, 2017 - 11:16am
Source:
Drug Delivery Business News
News Tags:
OncoSec
Merck
drug-device combos
metastatic melanoma
ImmunoPulse IL-12
Keytruda
devices
Headline:
OncoSec inks deal with Merck to study drug-device therapy for metastatic melanoma
Do Not Allow Advertisers to Use My Personal information
